News

Hong Kong-Singapore rivalry gets heated as regulators exchange barbs

SFC decried allegations that Beijing exercises clout over the regulator.

Hong Kong-Singapore rivalry gets heated as regulators exchange barbs

SFC decried allegations that Beijing exercises clout over the regulator.

Central office tower loan may balloon as lead investor ditches sale

After China Energy withdrew, the $16.08b loan pricing rose 10bps.

Cathay Pacific bounces back from fuel-hedging hit with surprise H2 profit

This narrowed the full-year net loss to $1.26b, below analysts expectation of $2.26b.

Hong Kong banks can withstand another housing crash: S&P

They can maintain their credit profiles even if prices were to plunge by 30%.

Prime rate hike likely to take effect in Q4

Analysts waved off concerns that interest rates will immediately rise following the Fed’s tightening policies.

Close Chinese financial ties are both boon and bane for Hong Kong banks

The Mainland’s deleveraging programme will drive cross-border loan activity but pose risks to LGFVs.

SFC slaps Deutsche Bank with $8.3m fine

It violated short position reporting and made unlicensed regulated activities.

HKEX ties up with MSCI to launch new Asian futures offerings

The move aims to boost its derivative business which accounts for 18% of HKEX revenue in 2017.

New auto sales growth to slow down to 4.3% to 41,000 units

Rising borrowing costs is pushing the brakes on passenger car sales.

Residential projects dominate construction works in 2017

The gross value of home projects rose 1.4% in nominal terms to $66.1b.

Secondary home prices extend steep climb after rising 15.4% in January

Market prices increased for the 15th consecutive month but a slowdown may be looming.

Housing market defies cooling measures amidst aggressive market takeup

Wheelock & Co. sold all 750 apartments amidst a slew of 9,800 applications.

Smart card Octopus' dominance dampens Hong Kong's mobile payments growth

Smaller e-payments players are finding it hard to gain traction against the ubiquitous card.

Hua Medicine targets IPO amidst wider market access for biotech firms

The deal for the Shanghai-based diabetes drug developer could raise as much $300m.

Public healthcare system thrives amidst staggering surplus

Recurrent expenditure on healthcare grew by an average of 7% over the past decade.